A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
Center for International Blood and Marrow Transplant Research
Takeda
Thomas Jefferson University
Eli Lilly and Company
Cogent Biosciences, Inc.
Eli Lilly and Company
Massachusetts General Hospital
H. Lee Moffitt Cancer Center and Research Institute
Kedrion S.p.A.
Ossium Health, Inc.
Memorial Sloan Kettering Cancer Center
Center for International Blood and Marrow Transplant Research
Washington University School of Medicine
Eli Lilly and Company
Medical College of Wisconsin
University of Michigan Rogel Cancer Center
Nantes University Hospital
Brigham and Women's Hospital
Herlev and Gentofte Hospital
Eli Lilly and Company
M.D. Anderson Cancer Center
Stanford University
Pfizer
Fred Hutchinson Cancer Center
The First Affiliated Hospital of Guangzhou Medical University
Pfizer